Eli Lilly Expects Mounjaro to Maintain U.S. Leadership
Finance chief Lucas Montarce said Mounjaro’s U.S. revenue gained 41% to $5 billion in the latest quarter and pointed to strength outside the U.S.
Eli Lilly expects its diabetes drug Mounjaro to maintain its leadership in the U.S., finance chief Lucas Montarce says during a call with analysts. In the latest quarter, Mounjaro's U.S. revenue gained 41% to $5 billion. Montarce also pointed to strength for Mounjaro outside of the U.S.
in the peri…